-
Ouster of Peter Marks & Mass FDA Layoffs Have Biotech Sector Bracing for Regulatory Disruptions
03 Apr 2025 02:22 GMT
… proven vaccines and treatments to prevent and … Relyvrio, an Amylyx Pharmaceuticals drug for amyotrophic lateral … reduction will not affect drug, medical device, or food reviewers … rippling across the biotech industry. The Biotechnology Innovation Organization …
-
Relenza interactions: Alcohol, medications, and other factors
13 Mar 2025 20:46 GMT
… alcohol consumption during Relenza treatment.
If you have questions … nasal spray flu vaccine (FluMist, FluMist Quad), which is … t been enough clinical trials to determine whether … doctor or another healthcare professional before taking any medication. The drug …
-
AIM announces Paul Goepfert, MD, as the principal investigator for the planned clinical study of Ampligen and FluMist as a vaccine for avian influenza
28 Feb 2025 13:45 GMT
… to a previous clinical trial at UAB, which indicated … intranasal delivery of the FluMist seasonal influenza vaccine not … of an Investigational New Drug application and the eventual … broad spectrum activity in clinical trials for globally important cancers, …
-
AIM ImmunoTech announces a planned follow-up clinical study evaluating a combination treatment of AIM’s Ampligen® and AstraZeneca’s FluMist® to address the recent avian influenza outbreaks
07 Feb 2025 13:50 GMT
… intranasal delivery of the FluMist seasonal influenza vaccine … tolerated with no serious treatment-related adverse events.
… first-in-class investigational drug called Ampligen® (rintatolimod), … activity in clinical trials for globally important cancers …
-
Omvoh interactions: Alcohol, medications, and other factors
23 Jan 2025 23:27 GMT
… flu vaccine (FluMist). Talk with your doctor to avoid potentially … . For example, other drugs may be approved in … doctor will likely prescribe anti-TB medication before you start Omvoh treatment … ’t been enough clinical trials to determine whether Omvoh …
-
Weekly review: Top FDA approvals, videos of 2024
02 Jan 2025 19:25 GMT
… Hikma Pharmaceuticals, enhances access to GLP-1 medications, which … treatments. To address this, needle-free options are emerging, including the FDA … FDA expanded the indication for Influenza Vaccine Live (FluMist; … trials set for late 2024 and potential FDA …
-
Most influential drug approvals of 2024: GoodRx
03 Jan 2025 23:57 GMT
… type of schizophrenia medication approved in decades.
3. FluMist (influenza nasal vaccine … Alzheimer's drugs. The FDA approved the oral medication July 29.
7 … or without a statin. On March 22, the FDA also approved Nexletol …
-
19 drug approvals in 2024 that had 'big clinical impact,' according to GoodRx
01 Jan 2025 09:46 GMT
… the list in order of FDA approval date.
1. Dupixent – Additional … the newly approved drugs are nasal sprays, like FluMist, a nasal spray … over other medications recommended by clinical treatment guidelines or mainstay medical organizations.…
-
Contemporary Pediatrics’ top 3 FDA approvals of 2024
18 Dec 2024 13:29 GMT
… givinostat the first nonsteroidal drug approved to treat … the infectious disease space, FluMist (Influenza Vaccine Live; AstraZeneca … results of several clinical trials that demonstrated the … -Medication
6. Dupixent FDA approved as first and only treatment …
-
AstraZeneca: New drug data, promising earnings and a $3.5B R&D investment
12 Nov 2024 21:48 GMT
… TROPION-Lung05 Phase II trial, which showed that lung … with Tagrisso for the treatment of advanced or metastatic … nasal spray flu vaccine, FluMist, to be administered at … investigation over medical insurance fraud and illegal drug importation.
AstraZeneca …